<DOC>
	<DOCNO>NCT01129596</DOCNO>
	<brief_summary>The purpose study investigate follow donepezil hydrochloride administration patient mild moderate Alzheimer 's Disease clinical practice : cognitive function , Functional Assessment Staging ( FAST ) score , adverse events/adverse drug reaction , patient background .</brief_summary>
	<brief_title>Post-marketing Surveillance Long-term Administration Donepezil Hydrochloride -Investigation Clinical Condition Safety Patients With Alzheimer 's Disease-</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>Inclusion criterion : Patients diagnose Alzheimer 's Disease Diagnostic Statistical Manual Mental Disorders ( DSMIV ) . Patients diagnose mild moderate Alzheimer 's Disease , applicable FAST score 4 5 . Exclusion criterion : Patients history hypersensitivity component Aricept piperidine derivative . Patients register survey .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>